rediff.com
e.g. Tata motors, Reliance MF, 500570
Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (XT) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Half yearly results in brief
(Rs crore)
Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21
Sales 8.73 44.80 10.29 14.54 5.95
Operating profit 1.47 5.42 1.43 4.62 -1.73
Interest 0.17 0.15 0.16 0.25 0.04
Gross profit 3.03 6.15 1.30 1.82 0.86
EPS (Rs) 0.23 4.68 2.58 4.44 0.36
Half yearly  results in details
Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21
Other income 1.74 0.88 0.04 -2.55 2.63
Stock adjustment -0.84 1.79 -0.55 0.05 -0.79
Raw material 2.37 6.82 6.06 6.87 4.21
Power and fuel - - - - -
Employee expenses 2.81 2.72 2.50 2.73 2.17
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 2.92 28.05 0.85 0.26 2.09
Provisions made - - - - -
Depreciation 1.36 1.02 0.87 0.93 0.74
Taxation 0.65 - 0.03 0.20 0.07
Net profit / loss 1.02 5.13 0.40 0.69 0.06
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 43.79 10.96 1.57 1.57 1.57
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 16.86 12.11 13.87 31.75 -29.11
GPM (%) 28.99 13.47 12.64 15.19 10.01
NPM (%) 9.78 11.23 3.92 5.79 0.66
Close
Add Shukra Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Shukra Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close